Correlation Between BB Biotech and Glarner Kantonalbank

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BB Biotech and Glarner Kantonalbank at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BB Biotech and Glarner Kantonalbank into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BB Biotech AG and Glarner Kantonalbank, you can compare the effects of market volatilities on BB Biotech and Glarner Kantonalbank and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BB Biotech with a short position of Glarner Kantonalbank. Check out your portfolio center. Please also check ongoing floating volatility patterns of BB Biotech and Glarner Kantonalbank.

Diversification Opportunities for BB Biotech and Glarner Kantonalbank

0.61
  Correlation Coefficient

Poor diversification

The 3 months correlation between BION and Glarner is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding BB Biotech AG and Glarner Kantonalbank in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Glarner Kantonalbank and BB Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BB Biotech AG are associated (or correlated) with Glarner Kantonalbank. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Glarner Kantonalbank has no effect on the direction of BB Biotech i.e., BB Biotech and Glarner Kantonalbank go up and down completely randomly.

Pair Corralation between BB Biotech and Glarner Kantonalbank

Assuming the 90 days trading horizon BB Biotech AG is expected to under-perform the Glarner Kantonalbank. In addition to that, BB Biotech is 1.59 times more volatile than Glarner Kantonalbank. It trades about -0.1 of its total potential returns per unit of risk. Glarner Kantonalbank is currently generating about 0.21 per unit of volatility. If you would invest  2,200  in Glarner Kantonalbank on November 27, 2024 and sell it today you would earn a total of  70.00  from holding Glarner Kantonalbank or generate 3.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

BB Biotech AG  vs.  Glarner Kantonalbank

 Performance 
       Timeline  
BB Biotech AG 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in BB Biotech AG are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, BB Biotech is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Glarner Kantonalbank 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Glarner Kantonalbank are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively abnormal basic indicators, Glarner Kantonalbank may actually be approaching a critical reversion point that can send shares even higher in March 2025.

BB Biotech and Glarner Kantonalbank Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BB Biotech and Glarner Kantonalbank

The main advantage of trading using opposite BB Biotech and Glarner Kantonalbank positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BB Biotech position performs unexpectedly, Glarner Kantonalbank can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Glarner Kantonalbank will offset losses from the drop in Glarner Kantonalbank's long position.
The idea behind BB Biotech AG and Glarner Kantonalbank pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios